The Patient-Reported Outcomes, Community Engagement, and Language (PRO-CEL) Core enhances the objectives of the Center's research programs by supporting the array of MSK investigators who wish to capture self-reported information from culturally diverse patients, caregivers, clinical staff, and community members. The faculty of the PRO-CEL Core are nationally recognized social, behavioral sciences, and community-engagement experts who provide technical assistance to all users throughout their various stages of research, including grant and protocol development, research study assistant and support staff training, and result dissemination. The PRO-CEL Core aims to 1) provide expert consultation with respect to selection, analysis, and interpretation of psychometrically sound patient-reported outcomes (PROs) or other self-report instruments for the capture of health-related quality of life (HRQoL), health behavior change, symptom control, treatment-related adverse events (AEs), and quality of care; 2) support qualitative interview, focus group, and other observational research methodology for generating new testable hypotheses, developing novel assessment tools, and establishing cultural and linguistic equivalency of PRO measures; 3) provide pre-review and feedback of peer-reviewed funding applications consistent with ?best practices? in psychosocial, behavioral, and community-engaged oncology research, including culturally and linguistically responsive research; 4) assist with the creation of online surveys for data capture; and 5) provide methodological support for clinical trial, behavioral, and population-based research that seeks to engage community or minority populations. The services provided by the PRO-CEL Core have supported the research of 105 MSK investigators in the past year, and during the past grant period, the work of this Core has contributed to 397 peer-reviewed publications.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA008748-55
Application #
10084832
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-01-20
Project End
2023-12-31
Budget Start
2021-01-01
Budget End
2021-12-31
Support Year
55
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Kinsella, Netty; Helleman, Jozien; Bruinsma, Sophie et al. (2018) Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices. Transl Androl Urol 7:83-97
Staehler, M; Motzer, R J; George, D J et al. (2018) Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial. Ann Oncol 29:2098-2104
Cybulska, Paulina; Goss, Cheryl; Tew, William P et al. (2018) Corrigendum to ""Indications for and complications of transfusion and the management of gynecologic malignancies"" [Gynecol. Oncol. 146 (2017) 416-426]. Gynecol Oncol 148:235
Giulino-Roth, Lisa; O'Donohue, Tara; Chen, Zhengming et al. (2018) Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience. Leuk Lymphoma 59:1861-1870
Kidwell, Kelley M; Postow, Michael A; Panageas, Katherine S (2018) Sequential, Multiple Assignment, Randomized Trial Designs in Immuno-oncology Research. Clin Cancer Res 24:730-736
Dean, Jamie; Wong, Kee; Gay, Hiram et al. (2018) Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy. Clin Transl Radiat Oncol 8:27-39
Luo, Jun; Attard, Gerhardt; Balk, Steven P et al. (2018) Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting. Eur Urol 73:715-723
Morales, K A; Arevalo-Perez, J; Peck, K K et al. (2018) Differentiating Atypical Hemangiomas and Metastatic Vertebral Lesions: The Role of T1-Weighted Dynamic Contrast-Enhanced MRI. AJNR Am J Neuroradiol 39:968-973
Lee, Sang Ho; Rimner, Andreas; Gelb, Emily et al. (2018) Correlation Between Tumor Metabolism and Semiquantitative Perfusion Magnetic Resonance Imaging Metrics in Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 102:718-726
Ramaswamy, Kavitha; Forbes, Lauren; Minuesa, Gerard et al. (2018) Peptidomimetic blockade of MYB in acute myeloid leukemia. Nat Commun 9:110

Showing the most recent 10 out of 8799 publications